RMD
$77.00
Resmed
($1.03)
(1.32%)
RMD
Earnings Whisper ®
N/A
4th Quarter June 2017
Consensus:  $0.75
Revenue:  $548.75 Mil
Tuesday
Aug 1
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when RMD reports earnings?
Beat
Meet
Miss

Where is RMD's stock price going from here?
Up
Flat
Down
Stock chart of RMD
Analysts
Summary of analysts' recommendations for RMD
Score
Grade
Pivots
Resistance
$79.49
$78.87
$77.93

$77.31

Support
$76.37
$75.75
$74.81
Tweet
Growth
Description
ResMed Inc. is a leading designer, manufacturer and distributor of medical equipment for treating and diagnosing sleep disordered breathing. Sleep disordered breathing includes sleep apnea and related respiratory conditions. The company sells a comprehensive range of diagnostic and treatment devices in countries through a combination of wholly owned subsidiaries and independent distributors.
Peers
StrykerBoston ScientificAbbott LaboratoriesIntegra LifeSciences HoldingsBaxter InternationalC. R. BardBecton, Dickinson3MWatersHill-Rom Holdings